2024-29009. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-TS25-036, Identify and Evaluate Potential Risk Factors for ALS; Amended Notice of Closed Meeting

Document Headings

Document headings vary by document type but may contain the following:

1. the agency or agencies that issued and signed a document
2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
3. the agency docket number / agency internal file number
4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

See the Document Drafting Handbook for more details.

Department of Health and Human Services

Centers for Disease Control and Prevention

AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services.

ACTION:

Notice.

FOR FURTHER INFORMATION CONTACT:

Carlisha Gentles, Pharm.D., B.C.P.S., C.D.C.E.S., Scientific Review Officer, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341. Telephone: [phone]; Email: [e-mail].

SUPPLEMENTARY INFORMATION:

Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—TS25-036, Identify and Evaluate Potential Risk Factors for ALS; February 25-26, 2025, 10 a.m.-5 p.m., EST, web conference, in the original Federal Register notice. The meeting notice was published in the Federal Register on December 2, 2024, 89 FR 95215.

This meeting notice is being amended to change the meeting dates from a two-day meeting to a one-day meeting. The notice should read as follows:

Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—TS25-036, Identify and Evaluate Potential Risk Factors for ALS.

Date: February 25, 2025.

Time: 10 a.m.-5 p.m., EST.

The meeting is closed to the public.

The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.